Skip to content
Hikma Pharmaceuticals
-
Hikma Pharmaceuticals reports steady growth outlook ahead of AGM, expands inhalation platform
The company forecasts overall revenue growth of 2% to 4% in 2026, with operating profit projected between USD 720 million and USD 770 million.
-
Hikma launches exclusive distribution of Claritag® skin tag removal device in MENA
Claritag® utilizes a patented Squeeze & Freeze® technology, providing a fast and effective way for adults aged 21 and older to remove skin tags safely at home.